Alberta PrEP Cohort
Summary
The Alberta PrEP Cohort is looking to recruit eligible Alberta residents 18-years and older to gather real-world data on the behaviors of individuals at risk of HIV and the effectiveness of a daily pill used to prevent HIV transmission. PrEP stands for Pre-Exposure Prophylaxis is a Health Canada approved daily pill (medication) taken to prevent HIV infection. Interested participants will be asked to complete a survey upon joining the study and every six months afterwards for two years. Particiants will need to see a licensed PrEP presciber to start the medication and every 3 months afterwards based upon the funding requirements set out by the Alberta Government. For those that qualify, the medication is free of charge. Persons looking to start or already on PrEP are eligible to join this study.
Eligibility
Eligible gender: Transgender, Other, Male, Female
Eligible ages: 18 to 99
Accepts healthy participants: Yes
Inclusion criteria:
You are eligible to join this study if:
1) you are 18-years or older
2) qualify for prescription for PrEP based on the assessment of a physician
3) can read and write in English
Exclusion criteria:
If you are not at least 18-years old, do not qualify for PrEP, or can not read and write in English, you are not eligible for this study.
Participate
Fill out the following form if you want to participate in this research
Collection of personal information
Your personal information is collected under
the authority of section 33(c) of the Freedom of Information and Protection of Privacy Act. If
you have any questions about the collection or use of this information, please visit our
Access to Information page.
Additional information
Contact information
Caley Shukalek, MD, MSc, FRCPC Clinical Assistant Professor Cumming School of Medicine, University of Calgary General Internal Medicine & Infectious Disease (HIV/STI) pronouns: he/him/his
Principal investigator:
Caley Shukalek
Clinical trial:
No
REB-ID:
REB20-0393